Correction: Guidelines for Genetic Testing and Management of Alport Syndrome (Clin J Am Soc Nephrol. 2022;17(1):143–154. doi:10.2215/CJN.04230321)

0Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The authors wish to note that the following statement should have been included in the Acknowledgments: This research has been supported (not financially) by European Reference Network for Rare Kidney Disease, ERKNet. This ERN is partly cofunded by the European Union within the framework of the Third Health Programme “ERN-2016–Framework Partnership Agreement 2017–2021.”

Cite

CITATION STYLE

APA

Savige, J., Lipska-Zietkiewicz, B. S., Watson, E., Hertz, J. M., Deltas, C., Mari, F., … Flinter, F. (2023). Correction: Guidelines for Genetic Testing and Management of Alport Syndrome (Clin J Am Soc Nephrol. 2022;17(1):143–154. doi:10.2215/CJN.04230321). Clinical Journal of the American Society of Nephrology. American Society of Nephrology. https://doi.org/10.2215/CJN.04230321

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free